AYODELE JINADU: Open Payments
NPI 1851004055 · ORLANDO, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,912 in 77 payments from 15 companies in 2025. Trend: 2023 $1,221 · 2024 $2,773 · 2025 $2,912
Food & beverage: $2,912
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 10 | $535 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 9 | $521 |
| Neurocrine BioSciences, Inc. | 13 | $475 |
| Alkermes, Inc. | 12 | $293 |
| Otsuka America Pharmaceutical, Inc. | 4 | $270 |
| E.R. Squibb & Sons, L.L.C. | 7 | $230 |
| Janssen Pharmaceuticals, Inc | 4 | $197 |
| Lundbeck LLC | 5 | $119 |
| ABBVIE INC. | 4 | $87 |
| Vanda Pharmaceuticals Inc. | 2 | $55 |
Products named: Auvelity, CAPLYTA, INGREZZA, REXULTI, COBENFY, ARISTADA, INVEGA SUSTENNA, ABILIFY ASIMTUFII.
Industry payments across FL — which companies pay providers there.
